Mediar Therapeutics
Mediar Therapeutics is seeking an Associate Scientist or Senior Associate Scientist to join their protein engineering team, focusing on antibody and protein engineering projects. The role involves planning and executing lab experiments, expression and purification of antibodies, and biophysical characterization, while collaborating across cross‑functional teams.
Headquarters
Boston, Massachusetts, United States
Company Size
11-50 employees
Founded
2019
Mediar Therapeutics is a clinical-stage biotech focused on developing therapies to halt and reverse fibrosis by targeting the myofibroblast—the cell that deposits collagen and sustains the pro‑fibrotic microenvironment. The company pursues unexplored, mechanism-driven targets and is running clinical studies in multiple fibrosing diseases to translate those insights into new treatment options. Mediar’s approach centers on deactivating myofibroblasts to slow, and potentially reverse, fibrotic progression for patients and caregivers.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Mediar Therapeutics.
36% below the average for this role
Senior Scientist I (Protein & Antibody Production)
Exelixis
Scientist -Antibody Technologies – Required Flow Cytometry, Tissue Culture & lab Exp)
MillenniumSoft
Protein Scientist
Piramal Pharma Solutions
Senior Scientist II (Protein & Antibody Production)
Exelixis
Senior Scientist, Protein Engineering
Systimmune
Computational Protein Engineer
Bradford Consulting